首页> 美国卫生研究院文献>Scientific Reports >Lipidomic dysregulation within the lung parenchyma following whole-thorax lung irradiation: Markers of injury inflammation and fibrosis detected by MALDI-MSI
【2h】

Lipidomic dysregulation within the lung parenchyma following whole-thorax lung irradiation: Markers of injury inflammation and fibrosis detected by MALDI-MSI

机译:全胸肺照射后肺实质内的血脂异常:MALDI-MSI检测到的损伤炎症和纤维化标记

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radiation-induced lung injury (RILI) is a delayed effect of acute radiation exposure that can limit curative cancer treatment therapies and cause lethality following high-dose whole-thorax lung irradiation (WTLI). To date, the exact mechanisms of injury development following insult remain ill-defined and there are no FDA approved pharmaceutical agents or medical countermeasures. Traditionally, RILI development is considered as three phases, the clinically latent period, the intermediate acute pneumonitis phase and the later fibrotic stage. Utilizing matrix-assisted laser desorption ionization mass spectrometry imaging, we identified a number of lipids that were reflective of disease state or injury. Lipids play central roles in metabolism and cell signaling, and thus reflect the phenotype of the tissue environment, making these molecules pivotal biomarkers in many disease processes. We detected decreases in specific surfactant lipids irrespective of the different pathologies that presented within each sample at 180 days post whole-thorax lung irradiation. We also detected regional increases in ether-linked phospholipids that are the precursors of PAF, and global decreases in lipids that were reflective of severe fibrosis. Taken together our results provide panels of lipids that can differentiate between naïve and irradiated samples, as well as providing potential markers of inflammation and fibrosis.
机译:放射诱发的肺损伤(RILI)是急性放射线暴露的延迟效应,它可能会限制治愈性癌症治疗方法并在大剂量全胸肺照射(WTLI)后造成致死性。迄今为止,受伤害后伤害发展的确切机制仍然不清楚,并且没有FDA批准的药剂或医学对策。传统上,RILI的发展被认为是三个阶段,即临床潜伏期,中间急性肺炎阶段和后期纤维化阶段。利用基质辅助激光解吸电离质谱成像,我们确定了许多反映疾病状态或损伤的脂质。脂质在新陈代谢和细胞信号传导中起着核心作用,因此反映了组织环境的表型,使这些分子在许多疾病过程中起着关键的生物标志物的作用。我们检测到特定表面活性剂脂质的减少,而与全胸腔肺照射后180天每个样品中出现的不同病理无关。我们还检测到作为PAF前体的醚连接磷脂的区域增加,以及反映严重纤维化的脂质的整体减少。总而言之,我们的结果提供了可以区分原始样品和辐照样品的脂质组合,并提供了炎症和纤维化的潜在标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号